Search published articles


Showing 2 results for Chelidonium Majus

Simin Namvar Aghdash, Mansoure Mokhtari,
Volume 18, Issue 12 (3-2016)
Abstract

Background: Traditional medicinal herbs have remained as a component of disease treatment system of many societies in the world. Today, many scientists have paid attention to the use of medicinal herbs in the treatment of epileptic seizures, because epilepsy is one of the most common neuropsychological disorders in the world that have many serious physical, psychological, social, and economic consequences. The aim of this study was to investigate the effect of Chelidonium Majus extract in the treatment of seizure.

Materials and Methods: In this study 40 mice have been randomly chosen and divided into 5 groups including a control group that received only pentylenetetrazol, sham group that received distilled water and 3 experimental groups received aqueous extract of Chelidonium Majus in doses of 50,100 and 150 mg/kg for 4 weeks. 30 minutes after gavage with different doses of the extract or distilled water, pentylenetetrazol was injected to experimental and sham groups. Animals immediately were transferred to a special cage and the seizure behaviors and parameters were recorded by a camera. Then, the different phases of seizure, latency time for onset of seizure and seizure duration were evaluated.

Results: Data analysis indicated that the aqueous extract of Chelidonium Majus had a significant effect on PTZ-induced seizure.  Therapy by this extract increases latency time for onset of seizure and prevents progress of seizure phases.

Conclusion: The attained results showed that Chelidonium Majus extract has anticonvulsant effect on PTZ-induced seizure. Thus, it may be used in seizure treatment.


Roshanak Haji Mohammad Ali, Masoud Parsania, Gholamreza Amin,
Volume 21, Issue 3 (6-2018)
Abstract

Background and Aim: Herpes simplex virus type 1 (HSV-1) may lead to oral herpes, encephalitis and keratoconjunctivitis. Today, following the increasing of HSV-1 prevalence and drug resistance, there has been an interest in the use of natural substance. In this study, we assessed the effect of hexane and methanol extracts of Chelidonium majus L. against acyclovir-resistant HSV-1.
Materials and Methods: The toxicity threshold of Chelidonium majus L. hexane and methanol extracts on HeLa cell was determined with trypan blue and MTT methods. Their direct antiviral effects were evaluated against HSV-1. Different concentrations of extracts in different times of virus replication have been evaluated. In each stage, the viral titers were tested by TCID50 assay.
Findings: The methanol extract at the concentration of 200 µg/ml and hexane extract at the concentration of 600 µg/ml were determined as effective minimal cytotoxic concentration on HeLa cell line. These concentrations did not have significant virucidal effects on Herpes simplex virus. The maximum antiviral effects of methanol extract at the concentration of 200 µg/ml was exhibited 1 and 2 hours after virus adsorption and reduced virus titer 4 logTCID50 compared to the control. Hexane extract did not have antiviral effect.
Conclusion: methanol extract of chelidonium majus L. compared to hexane extract showed significant antiviral effect on acyclovir-resistant HSV-1. Further research is required to identify specific bioactive compounds of this plant in order to be used in anti-herpes drugs.


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb